Change font size

Select a location

United States International

Select a language

Take a closer look

The Scleral Spacing Procedure (SSP)

Refocus Group has developed the Scleral Spacing Procedure (SSP) for the treatment of presbyopia and glaucoma. SSP is a minimally invasive outpatient procedure that involves implantation of the PresVIEW™ Scleral Implant (PSI), a two-part clear plastic device that is roughly the size of a grain of rice.

Clinical research studies for SSP

Refocus Group is currently conducting clinical research studies using the PresVIEW™ Scleral Implant (PSI). These studies are designed to determine if implantation of the PSI device in the eye via the Scleral Spacing Procedure (SSP) will:

  • Reduce or eliminate the need for corrective eyewear arising from presbyopia; and/or,
  • Reduce intraocular pressure (IOP) to help treat glaucoma and ocular hypertension (OHT).

See if you’re eligible to participate in one of Refocus’s studies.